A study in ovarian cancer might offer valuable insights for us, as it revealed that EVs derived from TAMs encapsulate GATA-binding protein-3 (GATA3), which promotes chemotherapy resistance in ovarian cancer cells to DDP by upregulating the CD24/Siglec-10 axis [91]. This evidence concerns the gene GATA3 and ovarian cancer.